JP2020536925A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020536925A5 JP2020536925A5 JP2020520602A JP2020520602A JP2020536925A5 JP 2020536925 A5 JP2020536925 A5 JP 2020536925A5 JP 2020520602 A JP2020520602 A JP 2020520602A JP 2020520602 A JP2020520602 A JP 2020520602A JP 2020536925 A5 JP2020536925 A5 JP 2020536925A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- antigen
- immunogenic composition
- antigen sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000427 antigen Substances 0.000 claims 34
- 102000036639 antigens Human genes 0.000 claims 34
- 108091007433 antigens Proteins 0.000 claims 34
- 239000000203 mixture Substances 0.000 claims 25
- 230000002163 immunogen Effects 0.000 claims 19
- 229920001184 polypeptide Polymers 0.000 claims 12
- 102000004196 processed proteins & peptides Human genes 0.000 claims 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims 12
- 238000000034 method Methods 0.000 claims 10
- 229960005486 vaccine Drugs 0.000 claims 10
- 238000009472 formulation Methods 0.000 claims 6
- 238000004519 manufacturing process Methods 0.000 claims 5
- 208000028169 periodontal disease Diseases 0.000 claims 5
- 229940079593 drug Drugs 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 238000002360 preparation method Methods 0.000 claims 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 3
- 241000605894 Porphyromonas Species 0.000 claims 3
- 206010065687 Bone loss Diseases 0.000 claims 2
- 201000001245 periodontitis Diseases 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 1
- 230000000890 antigenic effect Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 101150009774 mfa1 gene Proteins 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 238000001243 protein synthesis Methods 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 229940021747 therapeutic vaccine Drugs 0.000 claims 1
- 230000014616 translation Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023061241A JP2023098935A (ja) | 2017-10-12 | 2023-04-05 | 歯周炎ワクチンおよび関連組成物ならびに使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762571582P | 2017-10-12 | 2017-10-12 | |
| US62/571,582 | 2017-10-12 | ||
| PCT/US2018/055496 WO2019075260A1 (en) | 2017-10-12 | 2018-10-11 | VACCINE AGAINST PERIODONTITIS AND ASSOCIATED COMPOSITIONS AND METHOD OF USE |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023061241A Division JP2023098935A (ja) | 2017-10-12 | 2023-04-05 | 歯周炎ワクチンおよび関連組成物ならびに使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020536925A JP2020536925A (ja) | 2020-12-17 |
| JP2020536925A5 true JP2020536925A5 (enExample) | 2021-11-25 |
| JP7258870B2 JP7258870B2 (ja) | 2023-04-17 |
Family
ID=64110091
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020520602A Active JP7258870B2 (ja) | 2017-10-12 | 2018-10-11 | 歯周炎ワクチンおよび関連組成物ならびに使用方法 |
| JP2023061241A Pending JP2023098935A (ja) | 2017-10-12 | 2023-04-05 | 歯周炎ワクチンおよび関連組成物ならびに使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023061241A Pending JP2023098935A (ja) | 2017-10-12 | 2023-04-05 | 歯周炎ワクチンおよび関連組成物ならびに使用方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US10835590B2 (enExample) |
| EP (1) | EP3694547A1 (enExample) |
| JP (2) | JP7258870B2 (enExample) |
| KR (2) | KR102530966B1 (enExample) |
| CN (1) | CN111225684A (enExample) |
| AU (1) | AU2018347511A1 (enExample) |
| CA (1) | CA3078630A1 (enExample) |
| EA (1) | EA202090908A1 (enExample) |
| IL (1) | IL273690A (enExample) |
| MA (1) | MA50363A (enExample) |
| MX (1) | MX2020003810A (enExample) |
| PH (1) | PH12020550239A1 (enExample) |
| SG (1) | SG11202003147XA (enExample) |
| WO (1) | WO2019075260A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10835590B2 (en) | 2017-10-12 | 2020-11-17 | Vaxcyte, Inc. | Periodontitis vaccine and related compositions and methods of use |
| WO2025019900A1 (en) * | 2023-07-26 | 2025-01-30 | Denteric Pty Ltd | Chimeric protein vaccine |
| CN116751292B (zh) * | 2023-07-31 | 2024-05-14 | 河南大学 | 牙龈卟啉单胞菌Mfa1单克隆抗体及其应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59128338A (ja) | 1982-12-08 | 1984-07-24 | Kitasato Inst:The | 歯周炎予防用ワクチン及びその製法 |
| AU682877B2 (en) | 1993-05-28 | 1997-10-23 | Chiron Corporation | Peptide inhibitors of urokinase receptor activity |
| AUPN627595A0 (en) * | 1995-10-30 | 1995-11-23 | University Of Melbourne, The | Diagnostics and treatments of periodontal disease |
| AU742668B2 (en) | 1996-03-22 | 2002-01-10 | Morehouse School Of Medicine | Immunogenic compositions comprising porphyromonas gingivalis peptides and methods |
| US6833262B1 (en) | 1999-04-21 | 2004-12-21 | University Of Georgia Research Foundation, Inc. | Polypeptide having amidolytic activity for a serpin |
| AUPQ065299A0 (en) | 1999-05-28 | 1999-06-24 | University Of Sydney, The | A method of prophylaxis and treatment and agents useful for same |
| AUPQ485999A0 (en) | 1999-12-24 | 2000-02-03 | Csl Limited | P. gingivalis antigenic composition |
| US7378101B2 (en) | 2001-12-21 | 2008-05-27 | Pfizer, Inc. | Vaccine for periodontal disease |
| GB0411150D0 (en) | 2004-05-19 | 2004-06-23 | Queen Mary & Westfield College | Vaccine |
| RU2012107993A (ru) | 2009-08-02 | 2013-09-10 | Санофи Пастер Лимитид | Полипептиды porhyromonas gingivalis |
| WO2011097688A1 (en) | 2010-02-12 | 2011-08-18 | The University Of Sydney | Protein domains and uses therefor |
| WO2011130544A2 (en) | 2010-04-14 | 2011-10-20 | Sutro Biopharma, Inc. | Monitoring a dynamic system by liquid chromatography-mass spectrometry |
| KR102018863B1 (ko) | 2012-10-12 | 2019-09-05 | 서트로 바이오파마, 인크. | 개선된 발현을 위해 박테리아 추출물 중 선택 단백질의 단백질분해 불활성화 |
| WO2017066719A2 (en) | 2015-10-14 | 2017-04-20 | Research Institute At Nationwide Children's Hospital | Hu specific interfering agents |
| US10835590B2 (en) | 2017-10-12 | 2020-11-17 | Vaxcyte, Inc. | Periodontitis vaccine and related compositions and methods of use |
-
2018
- 2018-10-11 US US16/158,155 patent/US10835590B2/en active Active
- 2018-10-11 SG SG11202003147XA patent/SG11202003147XA/en unknown
- 2018-10-11 CA CA3078630A patent/CA3078630A1/en active Pending
- 2018-10-11 MX MX2020003810A patent/MX2020003810A/es unknown
- 2018-10-11 EP EP18797289.8A patent/EP3694547A1/en active Pending
- 2018-10-11 KR KR1020207013299A patent/KR102530966B1/ko active Active
- 2018-10-11 CN CN201880065401.1A patent/CN111225684A/zh active Pending
- 2018-10-11 WO PCT/US2018/055496 patent/WO2019075260A1/en not_active Ceased
- 2018-10-11 EA EA202090908A patent/EA202090908A1/ru unknown
- 2018-10-11 AU AU2018347511A patent/AU2018347511A1/en not_active Abandoned
- 2018-10-11 MA MA050363A patent/MA50363A/fr unknown
- 2018-10-11 KR KR1020237015301A patent/KR20230066660A/ko not_active Ceased
- 2018-10-11 JP JP2020520602A patent/JP7258870B2/ja active Active
-
2020
- 2020-03-29 IL IL273690A patent/IL273690A/en unknown
- 2020-04-08 PH PH12020550239A patent/PH12020550239A1/en unknown
-
2021
- 2021-05-05 US US17/308,872 patent/US11701414B2/en active Active
-
2023
- 2023-04-05 JP JP2023061241A patent/JP2023098935A/ja active Pending
- 2023-05-30 US US18/325,563 patent/US12121575B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI537000B (zh) | 治療性疫苗 | |
| CN102256620B (zh) | 用于治疗阿尔茨海默氏病的免疫治疗组合物 | |
| JP2012506411A5 (enExample) | ||
| JP2010500399A5 (enExample) | ||
| JP2014518620A (ja) | リポソーム製剤 | |
| RU2018111760A (ru) | Вакцинные композиции, характеризующиеся улучшенной стабильностью и иммуногенностью | |
| JP2015178529A5 (enExample) | ||
| JP2012501959A5 (enExample) | ||
| JP2020528911A5 (enExample) | ||
| JP2014508734A5 (enExample) | ||
| JP2020536925A5 (enExample) | ||
| JP2015500827A5 (enExample) | ||
| JP2019531293A5 (enExample) | ||
| JP2023098935A5 (enExample) | ||
| Maier et al. | Modulation of the humoral and cellular immune response in Aβ immunotherapy by the adjuvants monophosphoryl lipid A (MPL), cholera toxin B subunit (CTB) and E. coli enterotoxin LT (R192G) | |
| BR112016023915B1 (pt) | Usos de fragmento de proteína m e composição | |
| BR112015023738B1 (pt) | Vacinas de nucleoproteina influenza | |
| JP2015529677A5 (enExample) | ||
| JP2015525794A5 (enExample) | ||
| JP7203015B2 (ja) | 免疫原性組成物 | |
| ES2547855T3 (es) | Procedimiento de desencadenamiento o inducción de una respuesta inmunitaria | |
| CN102488898B (zh) | 龋齿疫苗及制备方法 | |
| DK2393511T3 (en) | ADJACENT, OVERLAPPING PEPTIDES FOR THE TREATMENT OF birch pollen allergy | |
| PH12020550239A1 (en) | Periodontitis vaccine and related compositions and methods of use | |
| EP3661546B1 (en) | A vaccine for protection against streptococcus suis |